These smart glasses help people with macular degeneration by eliminating blind spots
Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.
Hosted on MSN8m
Astellas seeks conditional approval for GA treatment in Japan
Astellas Pharma has submitted a new drug application (NDA) to Japan's Ministry of Health, Labour and Welfare seeking ...
Serious eye disease Age-Related Macular Degeneration (AMD) recognized with official awareness month: Canadian Ophthalmological Society
The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...
Daily7h
FDA approves ranibizumab for treating diabetic macular edema
The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...
DURAVYU shows promise in Phase 2 trial for eye disease
WATERTOWN, Mass. - EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT), currently valued at $535 million, announced positive results from the Phase 2 VERONA clinical trial of DURAVYU™, its ...
Macular Degeneration Treatment Market Size is Projected to Reach USD 18.59 Billion by 2033, Growing at a CAGR of 7.06%: Straits Research
The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...
Managed Healthcare Executive1d
FDA Approves Susvimo for Diabetic Macular Edema
Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...
pharmaphorum9h
FDA expands label for Roche's eye disease implant Susvimo
The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...
INVISIONMAG8h
Prevent Blindness Declares February as AMD and Low Vision Awareness Month
The goal is to educate the public and professionals about AMD and support patients and families affected by vision impairment ...
Rio Blanco Herald Times1h
Increasing screen time has impacts on the physical body
Much like the fad of smoking in the 1950s and 1960s, technology has become a normal obsession of the public with little ...
Non-Infectious Macular Edema Treatment Market Is Projected To Expand At 6.9% CAGR To US$ 29.6 Billion By 2034 | Fact.MR Report
The adoption of telemedicine and remote monitoring technologies in ophthalmology to accelerate the market growth, says Fact.MR in its new market rese ...